Ketamine Therapy Blog — Mental Health Insights & Treatment Guides

Expert insights on ketamine therapy, depression, anxiety, PTSD, and mental health treatment — updated regularly by the Isha Health clinical team.

Volkow on Psychedelics for Addiction: APA 2026 Notes

May 25, 2026News

At APA 2026, NIDA Director Nora Volkow walked through evidence that psilocybin may help with alcohol use disorder, smoking cessation, and cocaine use disorder.

Ketamine for OCD: Stanford Trial Shows 3-Week Effect

May 24, 2026News

Stanford researchers presented unpublished APA 2026 data showing a single ketamine infusion dramatically reduces OCD symptoms — with effects lasting 3 weeks.

Why Most People Can't Access Modern Depression Treatments

May 23, 2026News

TMS, ketamine, and other interventional psychiatry treatments work, but most patients can't access them. Notes from an APA 2026 panel on the bottleneck.

The 40-Year Antidepressant Plateau: APA 2026 Findings

May 22, 2026News

At APA 2026, a leading depression researcher said: modern antidepressants are only modestly better than placebo, and 40 years of new drugs haven't changed it.

Vagus Nerve Stimulation for Depression: What It Is

May 21, 2026News

Vagus nerve stimulation (VNS) is an implanted treatment for depression that hasn't responded to multiple medications. What it is and who it helps.

APA 2026 Recap: Ketamine, OCD, and What Psychiatry Discussed

May 20, 2026News

A physician's plain-English notes from the American Psychiatric Association 2026 meeting — what the field is saying about antidepressants, ketamine, and OCD.

White House Accelerates Psychedelic Therapy for Serious Mental Illness: April 2026 Executive Order Explained

Apr 23, 2026Isha Team

A physician's read on the April 2026 White House executive order accelerating psychedelic therapy for serious mental illness — what changes, what doesn't, and.

The Matthew Perry Case - Prescribing Ketamine with Care and Context

Jul 29, 2025News

Prescribing ketamine with care and context ensures safe, effective treatment tailored to each patient’s needs, guided by clinical insight and compassion.

Expanding Access to Ketamine-Assisted Psychotherapy: A New Collaboration Between Alchemy and Isha Health

Apr 8, 2025

Discover how Alchemy Community Therapy Center and Isha Health are collaborating to support ketamine therapy-trained therapists through medical collaboration.

Psychedelic Therapy Legislation Expands Across the U.S.

Mar 31, 2025News

Several states are advancing psychedelics-related legislation, with bills in Virginia, New Mexico, New Hampshire, Kansas, and Washington shaping the future of.

FDA Expands Approval of Spravato: What This Means for Depression Treatment

Jan 23, 2025Isha Team

The FDA has expanded Spravato approval as a standalone depression treatment. See what the esketamine nasal spray means for treatment-resistant patients.

DEA Extends Telemedicine Prescribing Through 2026

Jan 6, 2025News

The DEA has extended telemedicine prescribing flexibilities for controlled substances through 2025, ensuring continued access to mental health treatments and.

Page 1 of 3